baber/WOPTO huggingface dataset:
Patent CY-1114995-T1 (CY)
Title: Συζευγματα με πολυμερες του κ-252α και παραγωγων αυτοy
Inventor: TRAVERSA SILVIO
IPC: C08G73/06
Filed: 2014-03-24
Abstract: Η παρούσα εφεύρεση σχετίζεται με νέα συζεύγματα με πολυμερή του K-252a και παραγώγων αυτού και με τη χρήση τους για την παρασκευή μιας φαρμακευτικής σύνθεσης χρήσιμης για την πρόληψη, ανακούφιση και θεραπεία παθολογικών καταστάσεων που σχετίζονται με κινάση. Ειδικότερα, η παρούσα εφεύρεση σχετίζεται με την πρόληψη, ανακούφιση και θεραπεία παθολογικών καταστάσεων που σχετίζονται με HMGB1. Σε μια συγκεκριμένη άποψη, η εφεύρεση σχετίζεται με τη χρήση των νέων συζευγμάτων με πολυμερή του K-252a και παραγώγων αυτού για την παρασκευή μιας φαρμακευτικής σύνθεσης χρήσιμης για την πρόληψη, ανακούφιση και θεραπεία νευρολογικών διαταραχών, νευροπαθειών και νευροεκφυλιστικών διαταραχών του κεντρικού και περιφερικού νευρικού συστήματος. Σε μια άλλη προτιμούμενη άποψη, η εφεύρεση σχετίζεται με τη χρήση συζευγμάτων με πολυμερή για την παρασκευή μιας φαρμακευτικής σύνθεσης χρήσιμης για την πρόληψη, ανακούφιση και θεραπεία δερματοπαθολογικών καταστάσεων, και ιδιαίτερα δερματοπαθολογικών καταστάσεων που σχετίζονται με υπερβολικό πολλαπλασιασμό κερατινοκυττάρων, και ιδιαίτερα με ψωρίαση. Σε μια άλλη προτιμούμενη άποψη, η εφεύρεση σχετίζεται με τη χρήση των συζευγμάτων με πολυμερή για την πρόληψη, ανακούφιση και θεραπεία πόνου που σχετίζεται με NGF. Ειδικότερα, η παρούσα εφεύρεση σχετίζεται με ένα σύζευγμα με πολυμερή του K-252a και παραγώγων αυτού, όπου το πολυμερές είναι πολυαιθυλενογλυκόλη ή μεθοξυ-πολυαιθυλενογλυκόλη τύπος (I).
Patent CY-1117518-T1 (CY)
Inventor: PEDERSEN HENRIK
IPC: C12P21/02
Filed: 2016-05-13
Abstract: The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of libraries which can be screened for  e.g . therapeutic activity.
Patent CY-1118101-T1 (CY)
Title: Φορεας κυτταρων που περιεχει κολλαγονο
Inventor: JUST LOTHAR
IPC: A61K47/42
Filed: 2016-10-13
Abstract: Η παρούσα εφεύρεση αφορά την χρήση μιας σύνθεσης που περιέχει κολλαγόνο για την καλλιέργεια βιολογικών κυττάρων, μια μέθοδο για την καλλιέργεια βιολογικών κυττάρων, μια μέθοδο για την εμφύτευση βιολογικού υλικού σε έναν οργανισμό και μια μέθοδο για την βελτίωση μιας σύνθεσης ως προς την καταλληλότητα της για την καλλιέργεια βιολογικών κυττάρων.
Patent CY-1118785-T1 (CY)
Title: Διαδικασια για την ανακτηση υδροχλωρικης ναλμεφενης
Inventor: DE FAVERI CARLA
IPC: C07D489/08
Filed: 2017-03-31
Abstract: Η παρούσα εφεύρεση σχετίζεται με μία βελτιωμένη διαδικασία για την ανάκτηση υδροχλωρικής ναλμεφένης [υδροχλωρική 17-(κυκλοπροπυλο-μεθυλο)-4,5-άλφα-εποξυ-6-μεθυλενομορφιναν-3,14-διόλη] από μια υδατική σύνθεση η οποία περιέχει ναλμεφένη και ορισμένες προσμείξεις.
Patent CY-1119044-T1 (CY)
Inventor: KIRK IAN ALASTAIR
IPC: E21B17/10
Filed: 2017-05-12
Abstract: A centraliser (10) is described. The centraliser has a body (12) with at least one low friction slider on the outer surface thereof, the slider comprising a blade (14) that is formed separately and is attached to the body. Optionally, the blade may consist entirely of a low-friction material or alternatively, the blade could comprise a low-friction coating.
Patent CY-1123605-T1 (CY)
Title: Συσκευη και μεθοδος βελτιωσης της ανταλλαγης δεδομενων εικονας βασει της αντιληπτικης μη γραμμικοτητας φωτεινοτητας σε διαφορετικες δυνατοτητες προβολης
Inventor: MILLER JON SCOTT
IPC: G06F3/14
Filed: 2020-11-30
Abstract: Μία φορητή συσκευή απεικόνισης διαθέτει έναν δέκτη δεδομένων ο οποίος είναι διαμορφωμένος ώστε να λαμβάνει κωδικοποιημένα δεδομένα εικόνας αναφοράς. Τα δεδομένα συμπεριλαμβάνουν τιμές κώδικα αναφοράς, οι οποίες κωδικοποιούνται από ένα εξωτερικό σύστημα κωδικοποίησης. Οι τιμές κώδικα αναφοράς αντιπροσωπεύουν στάθμες του γκρίζου αναφοράς, οι οποίες επιλέγονται με τη χρήση μίας συνάρτησης προβολής κλίμακας του γκρίζου αναφοράς η οποία βασίζεται στην αντιληπτική μη γραμμικότητα της ανθρώπινης όρασης η οποία προσαρμόζεται σε διαφορετικές στάθμες φωτός σε χωρικές συχνότητες. Η συσκευή απεικόνισης διαθέτει επίσης έναν μετατροπέα δεδομένων ο οποίος είναι διαμορφωμένος ώστε να αποκτά πρόσβαση σε μία χαρτογράφηση κώδικα μεταξύ των τιμών κώδικα αναφοράς και των ειδικών για συσκευή τιμών κώδικα της συσκευής απεικόνισης. Οι ειδικές για συσκευή τιμές κώδικα είναι διαμορφωμένες για την παραγωγή στάθμεων του γκρίζου οι οποίες είναι ειδικές για τη συσκευή απεικόνισης. Βάσει της χαρτογράφησης κώδικα, ο μετατροπέας δεδομένων είναι διαμορφωμένος για τη διακωδικοποίηση των κωδικοποιημένων δεδομένων εικόνας αναφοράς σε ειδικά για συσκευή δεδομένα εικόνας, τα οποία είναι κωδικοποιημένα με τις ειδικές για συσκευή τιμές κώδικα.
Patent CY-1124871-T1 (CY)
Title: Φαρμακευτικα σκευασματα που περιλαμβανουν παραγωγα φωσφοραμιδιου της 5-φθορο-2'-δεοξυουριδινη προς χρηση στη θεραπεια του καρκινου
Inventor: MCGUIGAN CHRISTOPHER
IPC: C07F9/6558
Filed: 2021-12-17
Abstract: Ένα φαρμακευτικό σκεύασμα κατάλληλο για ενδοφλέβια χορήγηση, όπου το εν λόγω σκεύασμα, το οποίο περιλαμβάνει ένα φωσφοραμιδικό παράγωγο της 5-φθορο-2'-δεοξυουριδίνης, δημοσιεύεται προς χρήση στη θεραπεία του καρκίνου, ειδικά στη θεραπεία του καρκίνου, όπου ο ασθενής εμφανίζει αντίσταση, για παράδειγμα, σε έναν ασθενή που έχει κύτταρα με χαμηλό επίπεδο πρωτεϊνών μεταφορέων νουκλεοσιδίου και/ή με κύτταρα με έλλειψη νουκλεοσιδικής κινάσης και/ή με κύτταρα μολυσμένα με μυκόπλασμα και/ή με κύτταρα με αυξημένο επίπεδο θυμιδυλικής συνθάσης.
Patent HR-P20100027-T1 (HR)
Title: Use of iron(iii) complex compounds
Inventor: TANNER-BAUMGARTNER JESSICA
IPC: A61K47/26
Filed: 2010-01-14
Abstract: The present invention relates to novel therapeutic uses of iron(III) complex compounds with carbohydrates or derivatives thereof, in the preparation of a medicament for improving immune defense and/or brain performance.
Patent HR-P20110020-T1 (HR)
Inventor: YOSHII HIROSHI
IPC: A01N47/36
Filed: 2011-01-12
Abstract: Herbicidna smjesa naznačena time da sadrži (A) 2-(4,6-dimetoksipirimidin-2-ilkarbamoilsulfamoil)-N,N-dimetilnikotinannid ili njihove soli te (B) N2-terc-butil-6-kloro-N4-etil-1,3,5-triazin-2,4-diannin ili njihove soli, pri čemu je omjer smjese od (A) i (B) takav da je (B) od 0.5 do 1,000 dijelova po težini prema 1 dijelu po težini od (A). Patent sadrži još 2 patentna zahtjeva.
Patent HR-P20110479-T1 (HR)
Title: Natural mineral water for use in prophylaxis, hygiene and treatment of teeth and paradontium disease
Inventor: CIESLIK TADEUSZ
IPC: A23L1/304
Filed: 2011-06-28
Abstract: The invention refers to a new application of mineral water in prophylaxis of dental and paradontium diseases, when water has the following physiochemical and biological properties : Ph 7,6 - 8,1; electrolytic conductivity 180 - 210 µS/cm at 20°C, hardness 110 - 150 mg Ca CO 3 /l; chlorides 0,5 - 2,5 mg Cl/l; fluorides 0,01 - 0,03 mg F/l; sodium 0,6 - 1,6 mg Na/l; potassium 1,2 - 2,2 mg K/l; calcium 30 - 40 mg Ca/l; magnesium 5 - 14 mg Mg/l; faecal coli bacteria (thermotolerant) 0 in 100 ml; coli bacteria 0 in 100 ml; enterococcus 0 in 100 ml; clostridium perfrigens 0 in 100 ml; total number of bacteria at 37°C after 24 hours from 1 to 2 in 1 ml and total number of bacteria at 22°C after 72 hours from 3 to 5 in 1 ml.
Patent SI-1282398-T1 (SI)
Title: Inhalation therapy decongestant with foraminous carrier
Inventor: GOON DAVID
IPC: A61K9/70
Filed: 2000-05-12
Abstract: A vaporizable decongestant is supported and stabilized on a flexible foraminous carrier composed typically of open-cell plastic foam, cloth or other fibrous material such as nonwoven fabric. The term "foraminous" herein is intended to refer to a substance or medium containing minute openings or perforated by many minute apertures. The decongestant is placed on the surfaces within the interstices and minute apertures or on fibers from which the foraminous carrier is formed. Vaporization of the inhalable decongestant is facilitated by providing the potential for greatly increasing its exposed surface area. Distributing the decongestant composition over the large, expanded surface within the foraminous carrier is beneficial in enhancing both the volatilization and evaporation of the decongestant agent. It also prolongs the useful life of the product. Once vaporized, the aromatic decongestant is available for natural inhalation through the nose or mouth to help relieve one or more of the symptoms of cough, colds, nasal or chest congestion and related symptoms. The foraminous carrier is preferably provided in the form of a patch or sheet that is bonded to the skin to serve as a supporting base for the active decongestant agent. The patch defining the carrier is typically adhesively bonded to the upper part of the body, <i>e.g.</i> on the face, neck or chest, in a location where the decongestant is liberated into the air and can be inhaled through the mouth or nose.
Patent SI-1781291-T1 (SI)
Title: Opioids for the treatment of the restlessness of the lower limbs
Inventor: FLEISCHER WOLFGANG
IPC: A61K31/485
Filed: 2005-06-01
Abstract: The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with restless leg syndrome (RLS).
Patent SI-1917198-T1 (SI)
Title: Aromatic fibrous strip for consumer pack
Inventor: PHAM XUAN
IPC: B65D75/00
Filed: 2006-07-27
Abstract: A consumer pack with flexible outerwrap around the pack has a tear tape between the pack and the outerwrap for separating the outerwrap into upper and lower portions when the consumer pack is opened. A multi-layer aromatic strip is positioned on an outer surface of the outerwrap just outside the tear tape, and the aromatic strip is secured thereto by an adhesive layer. The aromatic strip includes a fibrous substrate soaked with fragrance and an outer barrier surface that seals in the fragrance. When the tear tape separates the outerwrap into upper and lower portions, the outer barrier surface and the fibrous substrate are broken open to release fragrance to the surroundings.
Patent SI-1973677-T1 (SI)
Title: Composite electrical conductor and method for producing it
Inventor: PUPKE FRANK
IPC: B21C23/00
Filed: 2006-12-18
Abstract: An electrical composite conductor includes a CuAg alloy base having an Ag content of 0.08 to 0.12% and a CuMg alloy having a Mg content of 0.1 to 0.7%. The composite conductor further includes a conductor edge and a conductor core, wherein at least one of the edge and the core include the CuMg alloy.
Patent TR-200801411-T1 (TR)
Title: Bir yakıcı.
Inventor: KURT ISMET
IPC: F23D14/06
Filed: 2006-07-13
Abstract: Bu buluş, gazlı ocaklarda kullanılan ve birden çok alev tacı içeren yakıcılar ile ilgilidir. Bu buluşun amacına ulaşmak için gerçekleştirilen yakıcı, en temel halinde, alev taçlarım üzerinde bulunduran bir tabla, tablanın altına sabitlenen ve venturi odasını üzerinde bulunduran bir tabla altı, tabla altının üzerine oturarak odanın üstünü kapatan ve venturi etkisinin oluşmasını sağlayan bir oda kapağı, alev taçlarının üzerini kapatan en az bir alev kapağı ve tabla altının içine oturduğu bir havuzu içermektedir.
Patent DE-3685629-T2 (DE)
Inventor: AUSTIN KENNETH
IPC: H03K19/173
Filed: 1986-09-10
Granted: 1993-02-11
Abstract: A gated binary signal transmission circuit in a field effect semiconductor chip comprises a single signal-pass transistor (20A, B) connected between a bit signal input (28A, B) to one of its electrodes (24A, B) and a bit signal output (12A, B) from another of its electrodes (26A, B). Its control electrode (22A, B) is connected for temporary energisations by switching circuitry (32,34) operative only at prescribed intervals, the single signal-pass transistor (20A, B) being operative to pass signals between such energisations of its control electrode (22A, B). Conduction of the single signal-pass transistor between energisations will persist, though with some decay, due to inherent capacitance and the control electrode being left "floating" between energisations.
Patent DE-3784455-T2 (DE)
Inventor: NIIRA REIJI
IPC: A01N59/16
Filed: 1987-12-04
Granted: 1993-06-09
Abstract: An antibiotic zeolite and an antibiotic resin composition containing thereof are provided. The antibiotic zeolite is prepared by replacing all or a part of ion-exchangeable ions in zeolite with ammonium ions and antibiotic metal ions such as silver, copper, zinc, mercury, tin, lead, bismuth, cadmium, chromium and thallium. The antibiotic resin composition comprises the antibiotic zeolite and a resin such as polyethylene, polypropylene, polyvinyl chloride and polystyrene.
Patent DE-3785761-T2 (DE)
Inventor: COWAN CARL
IPC: G03G15/01
Filed: 1987-02-25
Granted: 1993-12-02
Abstract: Electrophotographic color proof generating apparatus includes a charger station, an exposure station, and a development station. Starting with color half-tone separations of artwork, the apparatus, using a unique method, electronically controls the exposure and potentials at the charger and development stations to generate a proof. The apparatus is designed to generate proofs which match the dot gain or loss and density of press sheets printed by a great variety of commercial presses starting with the same separations as are used to form the proofs. The separations are then modified until the apparatus generates a proof which is an acceptable reproduction of the artwork. The modified separations are then used to generate a press sheet on the commercial press which will be an acceptable reproduction of the artwork.
Patent DE-3788693-T2 (DE)
Inventor: TOBOL HELEN K
IPC: C07D213/69
Filed: 1987-09-01
Granted: 1994-04-28
Abstract: 3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine, which can be prepared from 2,3,4,5-tetrachloro-6-(trichloromethyl)pyridine and an alkali metal methoxide, is an anticancer agent especially useful for the treatment of leukemias, lymphomas, mammary carcinomas, and ovarian sarcomas.
Patent DE-3850180-T2 (DE)
Inventor: CASTEELS PETER
IPC: A01N63/50
Filed: 1988-06-29
Granted: 1995-03-02
Abstract: The invention relates to new bactericidal and/or bacteriostatic thermostable peptides which are isolatable from hemolymph of immune honeybees and which are distinct from lysozymes, attacins, cecropins, diptericins ans magainins. They have bactericidal or bacteriostatic properties or both. They are useful in the field of therapy and prophilaxy in man or animal, in the field of plant pathogen control or in the field of food and feed control.
Patent DE-3872448-T2 (DE)
Inventor: STANZANI FRANCO
IPC: F04B35/04
Filed: 1988-03-01
Granted: 1992-12-03
Abstract: The motor-compressor unit structure as disclosed consists in a casing (3) the interior of which affords a chamber (4) for the compressor (1), and a housing (5) for the motor (2), the two separated in fluid-tight fashion by a bulkhead (6) through which a sealed passage is offered to the shaft (9) of the compressor (1); the casing (3) also exhibits a set of galleries (13) arranged peripherally around the housing (5), along which the refrigerant fluid is able to flow and thus keep the motor (2) at a given temperature.
Patent TR-199801330-T2 (TR)
Inventor: HALM HANS
IPC: A46B7/06
Filed: 1996-12-24
Abstract: Boyun bölgesinde, enlemesine olarak, plastik maddeye tutturulmus bir elastomerik madde kütlesiyle çevrelenmis bütünlesik inceltilmis bir bölüme sahip bir dis firçasi ki buradaki kütle, bagli oldugu uzunlamasina olarak komsu olan boyun ya da baslik bölümünün yüzey çizgisinin enlemesine olarak disina dogru sisen bir sekle sahiptir. Inceltilmis bölüm ve siskin kütle gelismis esneklige sahip bir dis firçasi saglar.
Patent TR-199802730-T2 (TR)
Inventor: BOURKE H STEVEN
IPC: C25D21/04
Filed: 1997-06-27
Abstract: Kapsamda, elektronik islemler esnasinda elektrolitik tanklarda yer alan elektrolitik banyolardan gelisen metal asit veya tuzlarin azaltilmasi için bir metod yer almaktadir. Bu metod, elektrolik banyonun yüzeyinin tamamini kirik köpük (ör. polimerik köpük, metal köpük, cam köpügü veya cam materyal köpügü) tabakasi ile kaplamayi kapsamaktadir. Kirik köpük sekilsizdir, uniform bir partikül boyutu yoktur, elektrolitik islevinde etkisizdir ve elektrolitik banyonun yüzeyine yüzer. Tercihen kirik köpük tabakasinin kalinligi yaklasik 3 ila 4 inçtir (76-102 mm). Bu bulustan faydalanma spesifik prosesin örnekleri, anodlama, galvanoplasti, elektrolitik maden istihsali ve elektroforez islevleridir.
Patent TR-199900780-T2 (TR)
Inventor: CLAYDON MARTIN ARTHUR
IPC: H01J49/00
Filed: 1997-08-26
Abstract: Bulus mikroorganizmalari nitelemek için bir yöntem ve cihaza iliskindir. Bulusta, bilinen bir mikroorganizmalar araligi için matris destekli lazer desorpsiyon iyonizasyon uçus zamani kütle spektrometrisi (MALDI-TOF-MS) spektral verileri kullanilir. Bu spektral veriler bilinen her mikroorganizmanin spektral verileri için bir veritabanina dahil edilir. Teshis edilmemis bir mikroorganizmanin bir örnegi hazirlanir ve MALDI-TOF-MS teknikleriyle analize tabi tutularak bilinmeyen organizmanin spektral verileri elde edilir. Daha sonra bu veriler, uygun karsilastirma araçlari kullanilarak veritabanindaki spektral verilerle karsilastirilir. Benzerlik cinsi belirtir, aynilik ise spesifik  mikroorganizmayi belirtir. Bu analiz için kullanilan cihaz bir kez kurulup ayarlandiktan sonra kullaniminin nispeten kolay olmasi avantajina sahiptir.
Patent DE-60010764-T2 (DE)
Inventor: FORSTER BIRGIT
IPC: A01N43/653
Filed: 2000-03-21
Granted: 2004-10-07
Abstract: An agrochemical composition, comprising at least two active ingredient components together with a suitable carrier, wherein component I is   I) difenoconazole (=cis,trans-3chloro-4-Ä4-methyl-2-(1 H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-ylÜphenyl 4-chlorophenyl ether> and wherein component II is IIB) 4,5-dlmethyl-N-2-propenyl-2-(trlmethylsllyl)-3-thiophencarboxamid which is especially suitable in the control and prevention of disease infestation on seed.
Patent DE-60017158-T2 (DE)
Inventor: PATHMANABAN LESLIE
IPC: A61F2/00
Filed: 2000-10-04
Granted: 2005-12-29
Abstract: A carrier for heart valves allows the removal of a heart valve from the carrier without manual manipulation. In addition, the carrier minimizes or substantially eliminates leaking of preserving fluid during transportation and storage. The carrier includes ajar, a rinse cage, and a holder to which a heart valve is attachable. The rinse cage includes a first engagement structure, for example, a channel, and the holder includes a second engagement structure, for example, a groove, complementary to the first engagement structure for releasably engaging therewith. A heart valve attached to the holder is disposed or suspended within the rinse cage when the engagement structures are engaged. A heart valve attached to the holder is protected not only when within the jar but also when removed from the jar. The holder has a socket for engaging with a surgical handle used to remove the valve from the jar for rinsing and implantation. The carrier may include apparatus for limiting rotation of the holder relative to the rinse cage and rotation of the rinse cage relative to the jar, which apparatus allows a surgical handle to be securely and firmly attached to the holder with essentially one hand and without removing the valve from the jar. The jar includes a lid that may have a rotatable gasket and a flange. The jar may have an apex-like top surface for making a compressive seal against the gasket when the lid is tightened. The flange may have a vent for allowing gases between the gasket and the lid to escape during sterilization processes of the carrier.
Patent DE-60018386-T2 (DE)
Inventor: KLUTTZ BRIAN
IPC: C12Q1/68
Filed: 2000-09-29
Granted: 2005-12-29
Abstract: An instrument for conducting nucleic acid amplification reactions in a disposable test device. The test device includes a first reaction chamber containing a first nucleic acid amplification reagent (e.g., primers and nucleotides) and a second reaction chamber either containing, or in fluid communication, with a second nucleic acid amplification reagent (e.g., an amplification enzyme such as RT). The instrument includes a support structure receiving the test device. A temperature control system maintains the first reaction chamber at a first elevated temperature but simultaneously maintains the second nucleic acid amplification reagent at a second temperature lower than the first temperature so as to preserve the second nucleic acid amplification reagent. An actuator operates on a fluid conduit in the test device to place the first and second reaction chambers in fluid communication with each other after a reaction has occurred in the first reaction chamber at the first temperature. A pneumatic system is also provided that assists in fluid transfer of a reaction solution from the first chamber to the second chamber.
Patent DE-60019138-T2 (DE)
Inventor: KAMIYA HIROKI
IPC: C08F214/26
Filed: 2000-09-13
Granted: 2006-02-02
Abstract: A tetrafluoroethylene/ethylene copolymer and a film excellent in flexibility, durability, light transmittance, strength and non-tackiness, and applications thereof. Such a copolymer has a ratio of the polymerized units based on tetrafluoroethylene/the polymerized units based on ethylene, of from 35/65 to 65/35 (molar ratio), contains from 1 to 10 mol% of polymerized units based on an alkyl vinyl ester (the carbon number of the alkyl group is from 5 to 17, and when branched, from 9 to 17), is crystalline and has a volumetric flow rate of from 1 to 1000 mm<3>/sec.
Patent DE-60021185-T2 (DE)
Inventor: HSU TONY HSIN-CHUANG CITY
IPC: G02B3/08
Filed: 2000-08-16
Granted: 2006-01-12
Abstract: A method for manufacturing a plastic optical device on a substrate is disclosed. A preferred embodiment of the present invention comprises the steps of: providing a mold (300) with mold cavities, wherein the structure of the mold cavities is the reverse of the desired structure of the plastic optical structure; filling a shape material (110) in the mold cavities of the mold; joining the shape material with the substrate (200); hardening the shaping material; and removing the mold to obtain the plastic optical device. In addition, a step of generating a force on the substrate by a pressure generator, for example a roller (500), can be performed in order to fill the mold cavities with the shaping material and remove the bubbles in the shaping material. The method of the present invention is useful in the formation of various plastic optical devices, such as a concentric saw-toothed fresnel lens, a lenticular lens, a cylindrical lens, a spherical lens, an asphere lens, and a pyramidal lens, and can be applied to, for example, a rear TV or the backlight plate of a LCD display. The method of the present invention reduces production cost and can be used to manufacture a plastic optical device of high quality and large dimension without suffering from residual stress. <IMAGE>
Patent DE-60032512-T2 (DE)
Inventor: LE TOURNEUR GREGOIRE
IPC: H04M9/08
Filed: 2000-06-27
Granted: 2007-10-11
Abstract: The invention relates to a real time processing and management method for canceling out the echo between a loudspeaker (HP) and a microphone (M) of a computer terminal. Said method consists of establishing the loudspeaker signal or the microphone signal as a reference signal and synchronizing (A) the other signal with said reference signal, and (B) synchronizing the acquisition and audio reestablishment tasks. The delay that exists (rej) between the other signal and the reference signal is measured (C) and the existing delay value (rej) is validated (D) in order to control the delay applied to the reference signal starting from the current delay (rej). The invention can be used for computer terminals which are equipped with multi-tasks operating systems.
Patent DE-60033658-T2 (DE)
Inventor: SLIWKOWSKI MARK X
IPC: A61K39/395
Filed: 2000-06-23
Granted: 2007-11-22
Abstract: The present application discloses treatment of prostate cancer with anti-ErbB2 antibodies.